Fight Between Support & Resistance
Last Friday’s action was volatile with the op-ex short-covering apparently coming into play. Biotech was affected more than any other index.
If it really was short covering, then we already know what’s likely to happen next.
First, we’ll go over the charts and then build a case for the next probable direction.
The focus is on SPBIO, instead of IBB, as it’s the weakest of the two indices.
From a weekly standpoint, this is where SPBIO, left-off this past Friday.
Biotech SPBIO, Weekly Bar
Adding the mark-up to show we’re at support and resistance.
Getting closer in on that area.
We can see based on the price action itself, we’re at an important juncture.
Two years ago, in March of 2020, price action formed a support level.
Fast forward to now.
Price action bounced off that same level, attempted to move higher (for over three weeks), was rejected, moved lower, and last week, came back up for an underside test.
Most Probable Direction
If there was a short squeeze as a result of options expiration, fuel for that move is gone.
The options have expired.
in addition, that fuel was only able to get SPBIO, to the underside of resistance.
So, you can see where this is going.
Upside fuel is gone. SPBIO, is currently at underside resistance; most probable direction is down.
If the action from all-time highs during the week of February 12th, 2021, to the current support/resistance area is a trading range, then we may have a ‘Measured Move’ target as shown.
Under the current conditions, i.e., financial, societal, collapse along with the ‘elephant‘ going mainstream, a downside objective that’s an – 85.6%, decline from all-time highs, is entirely reasonable.
The 3X Inverse LABD, Weekly
The unmarked chart
First, the rule of alternation.
Last time is not this time.
Last time there was a reversal bar and the next week continued lower, then lower again and so on.
The rule of alternation says, whatever happened last time will not happen this time. Price action will (likely) have a different form.
Obviously, if the short squeeze referenced above is over and the trend remains down, one could expect LABD, price action to be higher at the next session (SPBIO, lower).
The weekly chart shows progression and location of the stop orders on LABD-22-03 (not advice, not a recommendation).
The initial stop has been moved up to last week’s low.
There may be a trading channel as well.
Potential exit target(s) if not stopped out, would be contact points at the upper channel line.
If the position is stopped out at the next session, we’ll re-evaluate.
If not, and SPBIO, continues to move lower (LABD, higher), we’ll be looking for additional confirmation of the right-side trend line and the next likely area to move the stop.
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279